Tex. Occ. Code Section 562.1085
Unused Drugs Returned by Certain Pharmacists


(a)

A pharmacist who practices in or serves as a consultant for a health care facility or a licensed health care professional responsible for administration of drugs in a penal institution, as defined by Section 1.07 (Definitions), Penal Code, in this state may return to a pharmacy certain unused drugs, other than a controlled substance as defined by Chapter 481 (Texas Controlled Substances Act), Health and Safety Code, purchased from the pharmacy as provided by board rule. The unused drugs must:

(1)

be approved by the federal Food and Drug Administration and be:

(A)

sealed in unopened tamper-evident packaging and either individually packaged or packaged in unit-dose packaging;

(B)

oral or parenteral medication in sealed single-dose containers approved by the federal Food and Drug Administration;

(C)

topical or inhalant drugs in sealed units-of-use containers approved by the federal Food and Drug Administration; or

(D)

parenteral medications in sealed multiple-dose containers approved by the federal Food and Drug Administration from which doses have not been withdrawn; and

(2)

not be the subject of a mandatory recall by a state or federal agency or a voluntary recall by a drug seller or manufacturer.

(b)

A pharmacist for the pharmacy shall examine a drug returned under this section to ensure the integrity of the drug product. A health care facility or penal institution may not return a drug that:

(1)

has been compounded;

(2)

appears on inspection to be adulterated;

(3)

requires refrigeration; or

(4)

has less than 120 days until the expiration date or end of the shelf life.

(c)

The pharmacy may restock and redistribute unused drugs returned under this section.

(d)

The pharmacy shall reimburse or credit the state Medicaid program for an unused drug returned under this section.

(e)

The board shall adopt the rules, policies, and procedures necessary to administer this section, including rules that require a health care facility to inform the Health and Human Services Commission of medicines returned to a pharmacy under this section.

(f)

The tamper-evident packaging required under Subsection (a)(1) for the return of unused drugs is not required to be the manufacturer’s original packaging unless that packaging is required by federal law.
Added by Acts 2003, 78th Leg., ch. 198, Sec. 2.126, eff. Sept. 1, 2003; Acts 2003, 78th Leg., ch. 321, Sec. 1, eff. June 18, 2003.
Amended by:
Acts 2005, 79th Leg., Ch. 349 (S.B. 1188), Sec. 14, eff. September 1, 2005.
Acts 2007, 80th Leg., R.S., Ch. 820 (S.B. 1896), Sec. 1, eff. June 15, 2007.

Source: Section 562.1085 — Unused Drugs Returned by Certain Pharmacists, https://statutes.­capitol.­texas.­gov/Docs/OC/htm/OC.­562.­htm#562.­1085 (accessed May 18, 2024).

562.001
Definitions
562.002
Legislative Intent
562.003
Disclosure of Price
562.004
Prescription Transmitted Orally by Practitioner
562.005
Record of Dispensed Drug or Biological Product
562.006
Label
562.007
Refills
562.008
Generic Equivalent or Interchangeable Biological Product Authorized
562.009
Requirements Concerning Selection of Generically Equivalent Drug or Interchangeable Biological Product
562.010
Responsibility Concerning Generically Equivalent Drug or Interchangeable Biological Product
562.011
Restriction on Selection of and Charging for Generically Equivalent Drug or Interchangeable Biological Product
562.012
Substitution of Dosage Form Permitted
562.013
Applicability of Subchapter
562.014
Narrow Therapeutic Index Drugs
562.015
Dispensing Directive
562.016
List of Approved Interchangeable Biological Products
562.0051
Communication Regarding Certain Dispensed Biological Products
562.052
Release of Confidential Records
562.053
Reports to Board
562.054
Emergency Refills
562.055
Report to Texas Department of Health
562.056
Practitioner-patient Relationship Required
562.057
Administration of Epinephrine
562.0061
Other Prescription Information
562.0062
Required Statement Regarding Medication Disposal
562.101
Supervision of Pharmacy
562.102
Confidential Record
562.103
Display of Licenses by Pharmacy
562.104
Toll-free Telephone Number Required
562.105
Maintenance of Records
562.106
Notification
562.107
Written Consumer Information Required
562.108
Emergency Medication Kits
562.109
Automated Pharmacy Systems
562.110
Telepharmacy Systems
562.112
Practitioner-patient Relationship Required
562.0141
Transplant Immunosuppressant Drug Product Selection Prohibited
562.0142
Adoption of Rules
562.151
Definitions
562.152
Compounding for Office Use
562.153
Requirements for Office Use Compounding
562.154
Distribution of Compounded and Prepackaged Products to Certain Pharmacies
562.155
Compounding Service and Compounded Drug Products
562.156
Compounded Sterile Preparation
562.0541
Emergency Refills of Insulin and Insulin-related Equipment or Supplies
562.1011
Operation of Class C Pharmacy in Certain Rural Hospitals
562.1045
Linking Internet Sites
562.1085
Unused Drugs Returned by Certain Pharmacists
562.1086
Limitation on Liability

Accessed:
May 18, 2024

§ 562.1085’s source at texas​.gov